PUBLICACIÓN
The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy
2025
DOI
10.1016/j.xcrm.2025.102120
AUTORES DE LA UEX
PUBLICACIÓN
The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy
2025
DOI
10.1016/j.xcrm.2025.102120
AUTORES DE LA UEX
